Product Program year 2024 Source: CMS Open Payments

Fibresolve

Device Pulmonology

Open in the dashboard

General payments

$1,422

5 payments

Research payments

$0

0 payments

Through program year 2024, $1,422 in general payments and $0 in research payments were reported against Fibresolve (Pulmonology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2024 General $1,422 5

Breakdown

Who paid General payments · program year 2024
  1. imvaria inc. $1,422 5 payments
Top recipients General payments · program year 2024
  1. Sunil Santhanakrishnan Pulmonary Disease · Phoenix, AZ $434 31% · 1 payment
  2. Robert Cobb Pulmonary Disease · Tucson, AZ $314 22% · 1 payment
  3. James Pharaoh Pulmonary Disease · Knoxville, TN $237 17% · 1 payment
  4. Michael Czarnecki Internal Medicine · Washington, DC $237 17% · 1 payment
  5. Eric Weaver Pulmonary Disease · Knoxville, TN $200 14% · 1 payment

Each share is of general payments naming this product in 2024.

Specialties paid General payments · program year 2024
  1. Pulmonary Disease Internal Medicine $1,185 83% · 4 practitioners
  2. Internal Medicine $237 17% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2024
  1. Arizona $749 53% · 2 recipients
  2. Tennessee $437 31% · 2 recipients
  3. District of Columbia $237 17% · 1 recipient

Each share is of general payments naming this product in 2024 where a state was reported.

5 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record